GKOS - GLAUKOS Corp

QQQ $ 610.72 $ 0.00 (0 %)

DIA $ 467.80 $ 0.00 (0 %)

SPY $ 672.36 $ 0.00 (0 %)

TLT $ 91.60 $ 0.00 (0 %)

GLD $ 380.71 $ 0.00 (0 %)

Previous Close

$ 76.63

Open

$ 77.07

Bid

$ 75.70 x 27

Ask

$ 75.91 x 65

Day's Range

$ 75.10 - $ 77.07

52 Week Range

$ 73.73 - $ 163.71

Volume

1,689,721

Average Volume

Market Cap

4.39B

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-04-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-24-2025	12-31-2024	10-K
4	11-04-2024	09-30-2024	10-Q
5	08-02-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-23-2024	12-31-2023	10-K
8	11-01-2023	09-30-2023	10-Q
9	08-02-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-24-2023	12-31-2022	10-K
12	11-04-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-08-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-10-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-02-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	02-28-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-06-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	02-28-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-07-2017	06-30-2017	10-Q
34	05-04-2017	03-31-2017	10-Q
35	03-15-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-04-2016	03-31-2016	10-Q
39	03-15-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BTIG Reiterates Buy on Glaukos, Maintains ...
10/20/2025 12:27:35

BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $104 price target.

The FDA Approves Glaukos' Epioxa HD/Epioxa...
10/20/2025 11:04:58

Expert Outlook: Glaukos Through The Eyes O...
10/13/2025 14:00:44

BTIG Maintains Buy on Glaukos, Lowers Pric...
10/13/2025 12:07:45

BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $118 to $104.

Citigroup Maintains Buy on Glaukos, Lowers...
10/07/2025 17:04:34

Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $140 to $110.

Goldman Sachs Initiates Coverage On Glauko...
10/01/2025 17:49:00

Goldman Sachs analyst David Roman initiates coverage on Glaukos (NYSE:GKOS) with a Buy rating and announces Price Target of ...

Expert Outlook: Glaukos Through The Eyes O...
09/22/2025 19:01:24

Truist Securities Maintains Buy on Glaukos...
09/22/2025 14:25:57

Truist Securities analyst Richard Newitter maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $126 to...

BTIG Reiterates Buy on Glaukos, Maintains ...
09/10/2025 10:37:24

BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $118 price target.

Wells Fargo Maintains Equal-Weight on Glau...
07/31/2025 15:40:42

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Equal-Weight and raises the price target from $86 t...

UBS Maintains Buy on Glaukos, Raises Price...
07/31/2025 13:04:34

UBS analyst Danielle Antalffy maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $125 to $134.

Glaukos Raises FY2025 Sales Guidance from ...
07/30/2025 20:13:39

Glaukos (NYSE:GKOS) raises FY2025 sales outlook from $475.00 million-$485.00 million to $480.00 million-$486.00 million vs $480...

Glaukos Q2 Adj. EPS $(0.24) Beats $(0.26) ...
07/30/2025 20:13:03

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.34...

Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

Glaukos Announces EU MDR Certification For...
06/25/2025 20:09:57

Morgan Stanley Maintains Underweight on Gl...
05/06/2025 14:38:09

Morgan Stanley analyst Patrick Wood maintains Glaukos (NYSE:GKOS) with a Underweight and lowers the price target from $110 t...

What 11 Analyst Ratings Have To Say About ...
05/02/2025 21:02:23

Stephens & Co. Maintains Overweight on Gla...
05/02/2025 16:53:58

Stephens & Co. analyst Mason Carrico maintains Glaukos (NYSE:GKOS) with a Overweight and lowers the price target from $1...

this-parsons-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-thursday

This Parsons Analyst Is No Longer Bullish;...
05/01/2025 17:40:53

Stifel Maintains Buy on Glaukos, Lowers Pr...
05/01/2025 16:07:15

Stifel analyst Thomas Stephan maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $140 to $115.